Cirugía mayor ambulatoria del cáncer de mama: factores relacionados con la conversión a hospitalización convencional

Velázquez, Raúl Medina; Díaz, Laura Jiménez; Carrión, Jezabel Fernández; Bermúdez, Clara Rosas; Curto, Montserrat Miralles; Mérida, María Asunción Acosta; Gómez, Joaquín Marchena

doi:10.1016/j.ciresp.2018.10.001

Cited by 9 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ambulatory surgery, or day surgery, is often associated with higher patient satisfaction and less exposure to nosocomial comorbidities. It has been increasingly accepted and generalized in several surgical fields and many countries worldwide in recent years [16][17][18] . In terms of effectiveness and safety, low overall mortality and re-admission rates were reported within 2-3 days after surgery and in a follow-up period of 30-60 days [19][20][21][22] .…”

Section: Discussionmentioning

confidence: 99%

Ambulatory Surgery Protocol for Endoscopic Endonasal Resection of Pituitary Adenomas: A Prospective Single-arm Trial with Initial Implementation Experience

Liu

Zheng

et al. 2020

Sci Rep

View full text Add to dashboard Cite

endoscopic endonasal transsphenoidal resection has been accepted as a routine therapy for pituitary adenoma, but the postoperative hospital stay is typically several days long. With the advantages of reduced cost and improved patient satisfaction, the application of ambulatory surgery (AS) has developed rapidly. However, AS was still rarely adopted in neurosurgery. Here we designed an AS treatment protocol for pituitary adenoma with the endoscopic endonasal approach (EEA), and reported our initial experiences regarding the safety and efficacy of the AS protocol. 63 patients who presented with pituitary adenoma were screened at the Department of Neurosurgery, Tangdu Hospital from July to September, 2017. A total of 20 pituitary adenoma patients who met the inclusion criteria underwent EEA surgery using this evidence-based AS protocol, which emphasized adequate assessment for eligibility, full preparation to minimize invasiveness, enhanced recovery, and active perioperative patient education. Of the 20 patients enrolled, 18 were discharged on the afternoon of the operation day with a median total length of stay (LOS) of 31 hours (range, 29-32) hours. The median LOS after surgery was 6.5 (range, 5-8) hours. Two patients were transferred from the AS protocol to conventional care due to intraoperative cerebrospinal fluid leakage (one case) and an unsatisfying post-anesthetic discharge score (one case). Complications included transient and reversible mild postoperative nausea and vomiting [visual analog scale (VAS) score <3], headache (VAS score <3) after the operation or early after discharge. No patient was readmitted. Our results supported the safety and efficacy of the AS protocol for pituitary adenoma patients undergoing EEA resection among eligible patients, and further evaluation of this protocol in controlled studies with a larger sample size is warranted. Current advances in perioperative surgical concepts and technologies promote the advent and prevalence of ambulatory surgery (AS) in several surgical fields. The use of AS has accounted for >60% of all surgeries performed in the United States, with improved patient satisfaction and reduced costs compared to traditional surgery 1. In the field of neurosurgery, although attempts had been made to resect supratentorial brain tumors and clip unruptured cerebral aneurysms on an outpatient basis 2,3. AS remains not widely adopted. The endoscopic endonasal approach (EEA) for the resection of pituitary adenomas has gained increasing acceptance over the past few decades. Evidence suggested that EEA features shorter operative time, minor surgical

show abstract

Section: Discussionmentioning

confidence: 99%

Ambulatory Surgery Protocol for Endoscopic Endonasal Resection of Pituitary Adenomas: A Prospective Single-arm Trial with Initial Implementation Experience

Liu

Zheng

et al. 2020

Sci Rep

View full text Add to dashboard Cite

show abstract

“…Surgical pathology of the breast, both oncological and non-oncological, is gradually being incorporated into the Service Portfolio of many ambulatory surgery centers (ASC) 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 . The degree of satisfaction with the performance of outpatient procedures is an indicator of the quality of any ASC.…”

mentioning

confidence: 99%

Profitability of the CMA Unit for breast pathology during the COVID-19 pandemic

Río

Andújar

Vallvey

2022

Cirugía Española (English Edition)

View full text Add to dashboard Cite

“…Rentabilidad de la Unidad de CMA para patologı ´a mamaria durante la pandemia COVID-19 Profitability of the CMA Unit for breast pathology during the COVID-19 pandemic La patologı ´a quiru ´ rgica de la mama, tanto oncolo ´gica como no oncolo ´gica, se esta ´incorporando de modo progresivo en la Cartera de Servicios de muchas Unidades de Cirugı ´a Mayor Ambulatoria (UCMA) [1][2][3][4][5][6][7][8] . El grado de satisfaccio ´n por la realizacio ´n de procedimientos en re ´gimen ambulatorio un indicador de calidad de cualquier UCMA.…”

unclassified

Rentabilidad de la Unidad de CMA para patología mamaria durante la pandemia COVID-19

2022

View full text Add to dashboard Cite

Cirugía mayor ambulatoria del cáncer de mama: factores relacionados con la conversión a hospitalización convencional

Cited by 9 publications

References 13 publications

Ambulatory Surgery Protocol for Endoscopic Endonasal Resection of Pituitary Adenomas: A Prospective Single-arm Trial with Initial Implementation Experience

Ambulatory Surgery Protocol for Endoscopic Endonasal Resection of Pituitary Adenomas: A Prospective Single-arm Trial with Initial Implementation Experience

Profitability of the CMA Unit for breast pathology during the COVID-19 pandemic

Rentabilidad de la Unidad de CMA para patología mamaria durante la pandemia COVID-19

Contact Info

Product

Resources

About